PRL-3 antibody combined with pemetrexed induces apoptosis of human lung adenocarcinoma cell line A549

Objective To investigate the effects of PRL-3 antibody and pemetrexed on proliferation, migration and apoptosis of A549 cells. Methods A549 cells were treated with PRL-3 antibody at different concentrations; CCK-8 method was used to measure the cell proliferation of human lung adenocarcinoma A549 ce...

Full description

Bibliographic Details
Main Author: SHENG Xin, LIU Dan, DENG Shu-kai
Format: Article
Language:zho
Published: Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College. 2020-05-01
Series:Jichu yixue yu linchuang
Subjects:
Online Access:http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/a190933.pdf
_version_ 1827390460339945472
author SHENG Xin, LIU Dan, DENG Shu-kai
author_facet SHENG Xin, LIU Dan, DENG Shu-kai
author_sort SHENG Xin, LIU Dan, DENG Shu-kai
collection DOAJ
description Objective To investigate the effects of PRL-3 antibody and pemetrexed on proliferation, migration and apoptosis of A549 cells. Methods A549 cells were treated with PRL-3 antibody at different concentrations; CCK-8 method was used to measure the cell proliferation of human lung adenocarcinoma A549 cells in each group; Transwell chamber assay was used to detect cell migration ability of A549 cells; Flow cytometry assay was used to measure the apoptosis rate of A549 cells; PRL-3, P-ERK and VEGF protein expressions of A549 cells were detected by Western bolt. Results 1)Compared with the control group, the inhibitory effect of PRL-3 antibody on proliferation of A549 cells increased with the increase of PRL-3 concentration (P<0.05); 2)The inhibitory effect of the combination group on proliferation and migration ability of A549 cells was more significant than that of the monotheraphy group (P<0.05); 3)The apoptosis rate of A549 cells in the combination group 34.63%±1.65% was better than that of PRL-3 antibody group 17.24%±1.15% and pemetrexed group 15.32%±1.82% (P<0.05); 4)Compared with the monotheraphy group, the expressions of PRL-3, P-ERK and VEGF proteins in the combination group decreased more significantly (P<0.05). Conclusions PRL-3 antibody combined with pemetrexed can inhibit the proliferation, migration and induce apoptosis of A549 cells as compared to the monotherapy group. The mechanism may be attributed to the inhibition of the expressions of PRL-3, P-ERK and VEGF protein.
first_indexed 2024-03-08T16:53:04Z
format Article
id doaj.art-7b477674f62845fd96dd0fd9abcb04bb
institution Directory Open Access Journal
issn 1001-6325
language zho
last_indexed 2024-03-08T16:53:04Z
publishDate 2020-05-01
publisher Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College.
record_format Article
series Jichu yixue yu linchuang
spelling doaj.art-7b477674f62845fd96dd0fd9abcb04bb2024-01-05T03:15:38ZzhoInstitute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College.Jichu yixue yu linchuang1001-63252020-05-01405678683PRL-3 antibody combined with pemetrexed induces apoptosis of human lung adenocarcinoma cell line A549SHENG Xin, LIU Dan, DENG Shu-kai0the First Department of Respiratory and Critical Care Medicine, the Affiliated Hospital of Southwest Medical University, Luzhou 646000, ChinaObjective To investigate the effects of PRL-3 antibody and pemetrexed on proliferation, migration and apoptosis of A549 cells. Methods A549 cells were treated with PRL-3 antibody at different concentrations; CCK-8 method was used to measure the cell proliferation of human lung adenocarcinoma A549 cells in each group; Transwell chamber assay was used to detect cell migration ability of A549 cells; Flow cytometry assay was used to measure the apoptosis rate of A549 cells; PRL-3, P-ERK and VEGF protein expressions of A549 cells were detected by Western bolt. Results 1)Compared with the control group, the inhibitory effect of PRL-3 antibody on proliferation of A549 cells increased with the increase of PRL-3 concentration (P<0.05); 2)The inhibitory effect of the combination group on proliferation and migration ability of A549 cells was more significant than that of the monotheraphy group (P<0.05); 3)The apoptosis rate of A549 cells in the combination group 34.63%±1.65% was better than that of PRL-3 antibody group 17.24%±1.15% and pemetrexed group 15.32%±1.82% (P<0.05); 4)Compared with the monotheraphy group, the expressions of PRL-3, P-ERK and VEGF proteins in the combination group decreased more significantly (P<0.05). Conclusions PRL-3 antibody combined with pemetrexed can inhibit the proliferation, migration and induce apoptosis of A549 cells as compared to the monotherapy group. The mechanism may be attributed to the inhibition of the expressions of PRL-3, P-ERK and VEGF protein.http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/a190933.pdflung cancer|pemetrexed|prl-3|p-erk|vegf
spellingShingle SHENG Xin, LIU Dan, DENG Shu-kai
PRL-3 antibody combined with pemetrexed induces apoptosis of human lung adenocarcinoma cell line A549
Jichu yixue yu linchuang
lung cancer|pemetrexed|prl-3|p-erk|vegf
title PRL-3 antibody combined with pemetrexed induces apoptosis of human lung adenocarcinoma cell line A549
title_full PRL-3 antibody combined with pemetrexed induces apoptosis of human lung adenocarcinoma cell line A549
title_fullStr PRL-3 antibody combined with pemetrexed induces apoptosis of human lung adenocarcinoma cell line A549
title_full_unstemmed PRL-3 antibody combined with pemetrexed induces apoptosis of human lung adenocarcinoma cell line A549
title_short PRL-3 antibody combined with pemetrexed induces apoptosis of human lung adenocarcinoma cell line A549
title_sort prl 3 antibody combined with pemetrexed induces apoptosis of human lung adenocarcinoma cell line a549
topic lung cancer|pemetrexed|prl-3|p-erk|vegf
url http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/a190933.pdf
work_keys_str_mv AT shengxinliudandengshukai prl3antibodycombinedwithpemetrexedinducesapoptosisofhumanlungadenocarcinomacelllinea549